MiraVista Diagnostics’ dedication to innovation and improved accessibility to high quality fungal diagnostics has created a Histoplasma Urine Antigen LFA.

MiraVista Diagnostics is leading the industry with a new Histoplama Urine Antigen LFA. The rapid, non-invasive test demonstrates 96% correlation with the MiraVista Histoplasma Antigen Quantitative EIA, can be operated in low complexity clinical settings and requires no additional materials or equipment.

Key Benefits and Features

40-minute turnaround time
CE-marked product
Accurate, visually detectable results
Non-invasive specimen collection
25 test per kit

Rapid diagnosis can help treatment begin more quickly, reduce duration of anti-fungal therapy and help the patient recover faster.

The Process
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo